Artemis Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $14.8M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.59M | Sell |
|
|||||
|
2023
Q1 | $106M | Sell |
|
|||||
|
2022
Q4 | $136M | Sell |
|
|||||
|
2022
Q3 | $142M | Buy |
|
|||||
|
2022
Q2 | $151M | Sell |
|
|||||
|
2022
Q1 | $145M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $11.5M | Buy |
|
|||||
|
2021
Q2 | $8.76M | Sell |
|
|||||
|
2021
Q1 | $56.1M | Sell |
|
|||||
|
2020
Q4 | $62.1M | Sell |
|
|||||
|
2020
Q3 | $62.7M | Sell |
|
|||||
|
2020
Q2 | $71.8M | Sell |
|
|||||
|
2020
Q1 | $101K | Buy |
|
|||||
|
2019
Q4 | $75.4M | Buy |
|
|||||
|
2019
Q3 | $16.2M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $23.3M | Sell |
|
|||||
|
2018
Q4 | $77M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $10.6M | Buy |
|
|||||
|
2017
Q2 | $8.8M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $7.25M | Buy |
|